16-1-21_gutmann_RJB_0053-700×467

New research from David Gutmann, MD, PhD, may help doctors determine which medical issues are likely to manifest in patients with the inherited cancer syndrome neurofibromatosis type 1 (NF1). The findings indicate that varying mutations in the NF1 gene may lead to different clinical outcomes. (Photo: Robert J. Boston/School of Medicine)